Risk of Upper Gastrointestinal Bleeding and the Degree of Serotonin Reuptake Inhibition by Antidepressants: A Case-Control Study

By Vidal Xavier   Ibáñez Luisa   Vendrell Lourdes   Conforti Ana   Laporte Joan-Ramon  

Drug Safety, Vol. 31, Iss. 2, 2008-01 ,pp. : 159-168

Adis International

Access to resources Recommend Favorite

Risk of Hospitalization for Hip Fracture and Pneumonia Associated with Antipsychotic Prescribing in the Elderly: A Self-Controlled Case-Series Analysis in an Australian Health Care Claims Database

By Pratt Nicole   Roughead Elizabeth E.  

Drug Safety, Vol. 34, Iss. 7, 2011-07 ,pp. : 567-575

Adis International

Access to resources Recommend Favorite

Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise

By  

Current Neuropharmacology, Vol. 7, Iss. 4, 2009-12 ,pp. : 331-336

Bentham Science Publishers

Access to resources Recommend Favorite

Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin–norepinephrine reuptake inhibitor

By Nichols Alice I   Tourian Karen A   Tse Susanna Y   Paul Jeffrey  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1565-1574

Informa Healthcare

Access to resources Recommend Favorite

What Factors Predict Potentially Inappropriate Primary Care Prescribing in Older People?: Analysis of UK Primary Care Patient Record Database

By Carey Iain M.  

Drugs & Aging, Vol. 25, Iss. 8, 2008-01 ,pp. : 693-706

Adis International

Access to resources Recommend Favorite